Authors :
Dr. Shiva Mishra
Volume/Issue :
Volume 11 - 2026, Issue 1 - January
Google Scholar :
https://tinyurl.com/mr3xezve
Scribd :
https://tinyurl.com/yhv9ywwx
DOI :
https://doi.org/10.38124/ijisrt/26jan767
Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.
Abstract :
Pharmacoeconomics is an important field in healthcare that evaluates the economic impact of pharmaceutical
interventions, aiming to optimize resource allocation while ensuring that best health outcomes can be achieved.
There are different types of pharmacoeconomic studies being employed like cost-benefit, cost-effectiveness, cost
minimization, cost-utility analysis so that the different pharmaceutical products and treatment strategies can be compared.
The main aim of strategies is to choose the least expensive alternative but without compromising the quality of patient care.
Keywords :
Pharmacoeconomics, Cost-Minimization Analysis, Cost-Effectiveness Analysis, Cost-Benefit Analysis, Cost-Utility Analysis.
References :
- Mueller, C; Shur, C.; O'Connell, J. (1997). "Prescription Drug Spending: The Impact of Age and Chronic Disease Status". American Journal of Public Health. 87 (10): 1626–29.
- Arnold, Renée J.G.; Ekins, Sean (2010). "Time for Cooperation in Health Economics among the Modelling Community". PharmacoEconomics. 28 (8): 609–613
- Drummond M. Pharmacoeconomics :friend or foe? Annals of the Rheumatic Diseases 2006;65 (Suppl III): iii44-iii47.
- Understanding cost-effectiveness: A detailed review -The British journal of ophthalmology 2000
- Walley T and Haycox A. Pharmacoeconomics :basic concepts and terminology. British Journal of Clinical Pharmacology 1997;43:343-348
- Bombardier C and Maetzel A. Pharmacoeconomic evaluation of new treatments : efficacy versus effectiveness studies? Ann Rheum Dis 1999; 58 (Suppl I):182-185
- Pharmacoeconomics:an overview-Universal Journal of Pharmacy 2018
- A comparative study to evaluate the effects of fluticasone nasal spray with oral bilastine versus mometasone nasal spray with oral bilastine in patients of moderate to severe rhinitis-Central Asian Journal of Medical and Natural Science 2023
- A study to evaluate pharmacoeconomics of antihypertensive drugs in a tertiary care teaching hospital- Journal of Drug Delivery and Therapeutics 2020.
- Drummond M, Smith GT , Wells N. Economic Evaluation in the Development of Medicines. Office of Health Economics, 1988, p33
- Lyles A . Recent trends in pharmacoeconomics :Needs and unmet needs. Eur J Pharm Sci. 2008; 34:S7-24
- Walker R, Whittlesea C. Clinical Pharmacy and Therapeutics, 5th ed. Edinburg: Churchill Livingstone; 2012,p.116-8
- Sanchez LA. Expanding the pharmacist’s role in pharmacoeconomics :how and why ? Pharmacoeconomics .1994;5:367-75
- Pharmacoeconomics. Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076893 [accessed on March 14,2015]
- Mauskopf JA. Why study pharmacoeconomics. Expert Rev Pharmacoecon Outcomes Res.2001;1(1):1-3
Pharmacoeconomics is an important field in healthcare that evaluates the economic impact of pharmaceutical
interventions, aiming to optimize resource allocation while ensuring that best health outcomes can be achieved.
There are different types of pharmacoeconomic studies being employed like cost-benefit, cost-effectiveness, cost
minimization, cost-utility analysis so that the different pharmaceutical products and treatment strategies can be compared.
The main aim of strategies is to choose the least expensive alternative but without compromising the quality of patient care.
Keywords :
Pharmacoeconomics, Cost-Minimization Analysis, Cost-Effectiveness Analysis, Cost-Benefit Analysis, Cost-Utility Analysis.